Investigators have unveiled for the first time that changes in certain genes affect an aggressive cancer, T-cell acute ...

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

A new blood test tracking genetic changes in stem cells may predict leukemia risk and age-related diseases—potentially ...

A joint project led by Professors Liran Shlush and Amos Tanay could fundamentally change the means of diagnosis and treatment ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

Even in their natural state, some asperigimycins killed leukemia cells in lab tests. But the researchers went further. By ...

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran ...

MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by genetic mutations or by external cues from the tumor microenvironment? Despite major strides in targeted therapies ...

Recent progress in the molecular genetics of acute myeloid leukemia (AML) has shown this disease to be more heterogeneous than previously realized. Recurrent cytogenetic and mutational changes in ...

The overall response rate, defined as no evidence of leukemia, was 88.4%. The complete remission rate, meaning no evidence of leukemia along with normal blood counts, was 67.4%.